Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsuyoshi Sugimoto

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Clinical Pharmacology|January 25, 2008
Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMsKatsuyoshi Sugimoto, Tsukasa Uno, Tomonori Tateishi
Therapeutic Drug Monitoring|June 4, 2008
The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazoleTsukasa Uno, Katsuyoshi Sugimoto, Kazunobu Sugawara, et al.
British Journal of Clinical Pharmacology|February 5, 2008
Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese populationKatsuyoshi Sugimoto, Tsukasa Uno, Hiroshi Yamazaki, et al.
Anticancer Research|May 23, 2002
Aberrant expression of cyclin A in laryngeal squamous cell carcinomaYouyi Dong, Li Sui, Yasuo Watanabe, et al.
Anticancer Research|August 15, 2002
Survivin expression in laryngeal squamous cell carcinomas and its prognostic implicationsYouyi Dong, Li Sui, Yasuo Watanabe, et al.
Oncology Reports|February 13, 2003
S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implicationsYouyi Dong, Li Sui, Yasuo Watanabe, et al.
Journal of Medicinal Chemistry|August 16, 2012
Design and characterization of a selenium-containing inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa), a zinc-containing metalloproteaseNobuko Yoshimoto, Tomoyuki Sasaki, Katsuyoshi Sugimoto, et al.
Cancer Letters|January 26, 2002
Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinomaYouyi Dong, Li Sui, Yasuo Watanabe, et al.
International Journal of Oncology|July 16, 2002
Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumorsLi Sui, Youyi Dong, Masayuki Ohno, et al.
Anticancer Research|January 18, 2003
Expression of p57kip2 and its clinical relevance in epithelial ovarian tumorsLi Sui, Youyi Dong, Masayuki Ohno, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Pharmacology|January 25, 2008
Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMsKatsuyoshi Sugimoto, Tsukasa Uno, Tomonori Tateishi
Therapeutic Drug Monitoring|June 4, 2008
The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazoleTsukasa Uno, Katsuyoshi Sugimoto, Kazunobu Sugawara, et al.
British Journal of Clinical Pharmacology|February 5, 2008
Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese populationKatsuyoshi Sugimoto, Tsukasa Uno, Hiroshi Yamazaki, et al.
Anticancer Research|May 23, 2002
Aberrant expression of cyclin A in laryngeal squamous cell carcinomaYouyi Dong, Li Sui, Yasuo Watanabe, et al.
Anticancer Research|August 15, 2002
Survivin expression in laryngeal squamous cell carcinomas and its prognostic implicationsYouyi Dong, Li Sui, Yasuo Watanabe, et al.
Oncology Reports|February 13, 2003
S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implicationsYouyi Dong, Li Sui, Yasuo Watanabe, et al.
Journal of Medicinal Chemistry|August 16, 2012
Design and characterization of a selenium-containing inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa), a zinc-containing metalloproteaseNobuko Yoshimoto, Tomoyuki Sasaki, Katsuyoshi Sugimoto, et al.
Cancer Letters|January 26, 2002
Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinomaYouyi Dong, Li Sui, Yasuo Watanabe, et al.
International Journal of Oncology|July 16, 2002
Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumorsLi Sui, Youyi Dong, Masayuki Ohno, et al.
Anticancer Research|January 18, 2003
Expression of p57kip2 and its clinical relevance in epithelial ovarian tumorsLi Sui, Youyi Dong, Masayuki Ohno, et al.
Pageof 3